China
· Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 11.59 billion. The enterprise value is 11.72 billion.
| Market Cap | 11.59B |
| Enterprise Value | 11.72B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jun 17, 2024 |
Share Statistics
Sinocare has 553.84 million shares outstanding. The number of shares has decreased by -0.52% in one year.
| Current Share Class | 553.84M |
| Shares Outstanding | 553.84M |
| Shares Change (YoY) | -0.52% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 24.04% |
| Owned by Institutions (%) | 28.94% |
| Float | 415.19M |
Valuation Ratios
The trailing PE ratio is 36.50 and the forward PE ratio is 26.78.
| PE Ratio | 36.50 |
| Forward PE | 26.78 |
| PS Ratio | 2.59 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 5.67 |
| P/FCF Ratio | 16.32 |
| P/OCF Ratio | 13.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.77, with an EV/FCF ratio of 16.50.
| EV / Earnings | 36.91 |
| EV / Sales | 2.62 |
| EV / EBITDA | 18.77 |
| EV / EBIT | 27.73 |
| EV / FCF | 16.50 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.62 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.10 |
| Debt / FCF | 0.97 |
| Interest Coverage | 9.52 |
Financial Efficiency
Return on equity (ROE) is 9.12% and return on invested capital (ROIC) is 5.84%.
| Return on Equity (ROE) | 9.12% |
| Return on Assets (ROA) | 4.47% |
| Return on Invested Capital (ROIC) | 5.84% |
| Return on Capital Employed (ROCE) | 9.27% |
| Revenue Per Employee | 929,746 |
| Profits Per Employee | 66,015 |
| Employee Count | 4,809 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 3.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.68% in the last 52 weeks. The beta is -0.06, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -24.68% |
| 50-Day Moving Average | 21.75 |
| 200-Day Moving Average | 24.32 |
| Relative Strength Index (RSI) | 42.27 |
| Average Volume (20 Days) | 3,878,184 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 4.47 billion and earned 317.47 million in profits. Earnings per share was 0.57.
| Revenue | 4.47B |
| Gross Profit | 2.42B |
| Operating Income | 422.57M |
| Pretax Income | 379.57M |
| Net Income | 317.47M |
| EBITDA | 609.26M |
| EBIT | 422.57M |
| Earnings Per Share (EPS) | 0.57 |
Balance Sheet
The company has 979.71 million in cash and 687.17 million in debt, giving a net cash position of 292.54 million or 0.53 per share.
| Cash & Cash Equivalents | 979.71M |
| Total Debt | 687.17M |
| Net Cash | 292.54M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | 3.85B |
| Book Value Per Share | 6.19 |
| Working Capital | 889.20M |
Cash Flow
In the last 12 months, operating cash flow was 859.99 million and capital expenditures -149.60 million, giving a free cash flow of 710.38 million.
| Operating Cash Flow | 859.99M |
| Capital Expenditures | -149.60M |
| Free Cash Flow | 710.38M |
| FCF Per Share | 1.28 |
Margins
Gross margin is 54.08%, with operating and profit margins of 9.45% and 7.10%.
| Gross Margin | 54.08% |
| Operating Margin | 9.45% |
| Pretax Margin | 8.49% |
| Profit Margin | 7.10% |
| EBITDA Margin | 13.63% |
| EBIT Margin | 9.45% |
| FCF Margin | 15.89% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.04%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 40.55% |
| Buyback Yield | 0.52% |
| Shareholder Yield | 1.56% |
| Earnings Yield | 2.74% |
| FCF Yield | 6.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Sinocare has an Altman Z-Score of 5.39.
| Altman Z-Score | 5.39 |
| Piotroski F-Score | n/a |